Gilman Hill Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $221K | Buy |
+3,158
| New | +$221K | 0.04% | 213 |
|
|
2024
Q4 | – | Sell |
-3,703
| Closed | -$289K | – | 221 |
|
|
2024
Q3 | $289K | Buy |
3,703
+1,125
| +44% | +$87.6K | 0.05% | 179 |
|
|
2024
Q2 | $201K | Sell |
2,578
-1,125
| -30% | -$87.7K | 0.04% | 202 |
|
|
2024
Q1 | $251K | Buy |
+3,703
| New | +$251K | 0.05% | 188 |
|
|
2023
Q3 | – | Sell |
-3,703
| Closed | -$265K | – | 206 |
|
|
2023
Q2 | $265K | Hold |
3,703
| – | – | 0.05% | 176 |
|
|
2023
Q1 | $257K | Hold |
3,703
| – | – | 0.05% | 177 |
|
|
2022
Q4 | $251K | Sell |
3,703
-2,030
| -35% | -$138K | 0.05% | 186 |
|
|
2022
Q3 | $314K | Sell |
5,733
-250
| -4% | -$13.7K | 0.07% | 166 |
|
|
2022
Q2 | $395K | Buy |
5,983
+1,500
| +33% | +$99K | 0.08% | 150 |
|
|
2022
Q1 | $297K | Hold |
4,483
| – | – | 0.07% | 170 |
|
|
2021
Q4 | $261K | Hold |
4,483
| – | – | 0.06% | 189 |
|
|
2021
Q3 | $269K | Buy |
+4,483
| New | +$269K | 0.07% | 177 |
|
|
2019
Q1 | – | Sell |
-5,850
| Closed | -$222K | – | 189 |
|
|
2018
Q4 | $222K | Hold |
5,850
| – | – | 0.09% | 153 |
|
|
2018
Q3 | $231K | Hold |
5,850
| – | – | 0.09% | 152 |
|
|
2018
Q2 | $205K | Buy |
+5,850
| New | +$205K | 0.08% | 160 |
|